[Federal Register Volume 77, Number 176 (Tuesday, September 11, 2012)]
[Pages 55845-55846]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-22210]



Food and Drug Administration

[Docket No. FDA-2012-N-0001]

Science Board to the Food and Drug Administration: Request for 

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.


SUMMARY: The Food and Drug Administration (FDA) is requesting 
nominations to serve on the Science Board to FDA (Science Board).
    FDA seeks to include the views of women and men, members of all 
racial and ethnic groups, and individuals with and without disabilities 
on its advisory committees and, therefore, encourages nominations of 
appropriately qualified candidates from these groups.

DATES: Nominations received on or before October 11, 2012 will be given 
first consideration for membership on the Science Board. Nominations 
received after October 11, 2012 will be considered for nomination to 
the Board should nominees still be needed.

ADDRESSES: All nominations for membership should be sent electronically 
to [email protected] or by mail to Advisory Committee Oversight and 
Management Staff, 10903 New Hampshire Ave., Bldg. 32, rm. 5103, Silver 
Spring, MD 20993-0002.

FOR FURTHER INFORMATION CONTACT: Regarding all nomination questions for 
membership, the primary contact is Martha Monser, Office of the Chief 
Scientist, Food and Drug Administration, 10903 New Hampshire Ave., 
Bldg. 32, rm. 4286, Silver Spring, MD 20993-0002, 301-796-4627, email: 
[email protected].

[[Page 55846]]

    Information about becoming a member on an FDA advisory committee 
can also be obtained by visiting FDA's Web site by using the following 
link http://www.fda.gov/AdvisoryCommittees/AboutAdvisoryCommittees/CommitteeMembership/default.htm.

SUPPLEMENTARY INFORMATION: FDA is requesting nominations to the Science 
Board. The Science Board will meet approximately three times a year. 
Meetings of the Science Board will be open to the public. All meetings 
will be announced in the Federal Register at least 15 days prior to 
each public meeting.

I. General Function of the Committee

    The Science Board shall provide advice primarily to the 
Commissioner and other appropriate officials on specific complex 
scientific and technical issues important to FDA and its mission, 
including emerging issues within the scientific community. 
Additionally, the Science Board will provide advice that supports the 
Agency in keeping pace with technical and scientific developments, 
including in regulatory science and input into the Agency's research 
agenda and on upgrading its scientific and research facilities and 
training opportunities. It will also provide, where requested, expert 
review of Agency sponsored intramural and extramural scientific 
research programs.

II. Desired Expertise

    FDA is specifically considering persons knowledgeable in the fields 
of food science, safety, and nutrition; chemistry; pharmacology; 
translational and clinical medicine and research; toxicology; 
biostatistics; medical devices; imaging; robotics; cell and tissue 
based products; regenerative medicine; public health and epidemiology; 
international health and regulation; product safety; product 
manufacturing sciences and quality; and other scientific areas relevant 
to FDA-regulated products such as systems biology, informatics, 
nanotechnology, and combination products. Members shall be chosen from 
academia and industry. The Science Board may also include technically 
qualified federal members.

III. Nomination Procedures

    Any interested person may nominate one or more qualified person(s) 
for membership on the Science Board. Self nominations are also 
accepted. Nominations shall include the name of the committee, complete 
curriculum vitae of each nominee, and their current business address 
and/or home address, telephone number, and email address, if available. 
Nominations must also acknowledge that the nominee is aware of the 
nomination unless self-nominated. FDA will ask the potential candidates 
to provide detailed information concerning such matters related to 
financial holdings, employment, and research grants and/or contracts to 
permit evaluation of possible sources of conflict of interest.
    This notice is issued under the Federal Advisory Act (5 U.S.C. app. 
2) and 21 CFR part 14 relating to advisory committees.

    Dated: Sept. 5, 2012.
Jill Hartzler Warner,
Acting Associate Commissioner for Special Medical Programs.
[FR Doc. 2012-22210 Filed 9-10-12; 8:45 am]